Are patients with elevated liver tests at increased risk of drug-induced liver injury?

Do Hepatotoxicity Registries Have a Role in Health Care?

Drug-Induced Liver Injury, Dosage, and Drug Disposition: Is Idiosyncrasy Really Unpredictable?

HAART and the HCV-infected liver: friend or foe?

Liver Injury Associated With Drugs and Complementary and Alternative Medicines in India

Drug induced liver injury and its relationship to autoimmune hepatitis

Approach to the patient with acute severe autoimmune hepatitis.

Are HIV-infected patients candidates for liver transplantation?

Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic.

Toward an Improved Definition of Acute-on-Chronic Liver Failure

Pathogenesis and Treatment of Hepatitis E Virus Infection

Management of patients with hepatitis B virus-induced cirrhosis

Direct-acting antivirals trump interferon-alpha in their capacity to rescue exhausted T cells upon HCV clearance

Time-dependent events in natural history of occult hepatitis B virus infection: the importance of population-based long-term follow-up study with repeated measurements

Hepatitis viruses and human immunodeficiency virus co-infection: pathogenisis and treatment

Herbal medicine hepatotoxicity: A new step with development of specific biomarkers